May 13, 2022
With the backing of new laws, retail pharmacists have considerable freedom to switch patients to FDA approved interchangeable biosimilars. While most are willing to use that freedom, according to a new report, unanswered questions remain.
May 11, 2022
Things are looking up for patients who have an uncommon heart condition. The Food and Drug Administration last month approved a novel medication to treat obstructive hypertrophic cardiomyopathy.
May 9, 2022
With the finalization of a controversial draft policy, one federal agency dashed the hopes of millions of people living with Alzheimer’s and related dementias.
May 6, 2022
By Robert Fekete, MD - Getting tardive dyskinesia is devastating for mental health patients who are getting back on track.
May 5, 2022
What is medical innovation worth? To explore this question, the Institute for Patient Access recently convened health policy and patient advocacy professionals for the Value of Innovation Policy Forum in Washington, D.C.
April 29, 2022
Treating patients with rheumatic diseases often involves using biologic medications, including biosimilars.
April 25, 2022
No parent wants to see their child wince in pain or hear their baby cry. Yet enduring the undesirable for just a minute – as the child is vaccinated – can save heartache down the road.
April 21, 2022
What stands between rare cancer patients and life-saving treatment? A 3-to-7-character alpha-numeric code.
April 19, 2022
By Chloe Villavaso, MN, APRN, CNS - When I became an advanced practice nurse, I never thought I’d be competing with the television for my patient’s trust. Yet here I am.
April 14, 2022
Technology continues to revolutionize how patients and providers tackle complex medical conditions. The latest example? Prescription digital therapeutics.
